The Endocannabinoid System: Current Pharmacological Research and Therapeutic Possibilities
Authors:
- 30 January 2006
- journal article
- review article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 98 (2) , 124-134
Abstract
In the relatively short period of time since the discovery of cannabinoid receptors and their endogenous ligands, the endocannabinoids, an intensive research effort has resulted in the identification of agents that affect all aspects of the endocannabinoid system. The cannabinoid1 receptor antagonist rimonabant is in phase III clinical trials for the treatment of obesity and as an aid to smoking cessation, and cannabinoid2 receptor agonists are promising in animal models of inflammatory and neuropathic pain. In the present MiniReview, the endocannabinoid system is described from a pharmacological perspective. The main topics covered are: the mechanism of action of cannabinoid2 receptor agonists; identification of the endocannabinoid(s) involved in retrograde signalling; the elusive mechanism(s) of endocannabinoid uptake; therapeutic possibilities for fatty acid amide hydrolase inhibitors; and the cyclooxygenase‐2 and lipoxygenase‐derived biologically active metabolites of the endocannabinoids.Keywords
This publication has 131 references indexed in Scilit:
- The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of β-hexosaminidase from skin slices in vitroLife Sciences, 2006
- Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampusNature Neuroscience, 2005
- Anandamide transport: A critical reviewLife Sciences, 2005
- Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: Review of the available pre-clinical data, and first human studiesNeuropharmacology, 2005
- The spatial and temporal pattern of fatty acid amide hydrolase expression in rat hippocampus during postnatal developmentEuropean Journal of Neuroscience, 2004
- Endocannabinoid transport tightly controls 2‐arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404European Journal of Neuroscience, 2004
- Phylogenomic and chemotaxonomic analysis of the endocannabinoid systemBrain Research Reviews, 2004
- Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agentsBrain Research Reviews, 2003
- Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compoundsLife Sciences, 1984
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964